Octreotide scan

From Food & Medicine Encyclopedia

(Redirected from Indium-111 pentetreotide)

Octreotide scan is a type of nuclear medicine imaging technique that uses a radiolabeled form of the drug octreotide to detect certain types of cancer. This scan is particularly useful in identifying neuroendocrine tumors, which often express somatostatin receptors that bind to octreotide.

Procedure[edit]

The octreotide scan procedure involves the intravenous injection of a small amount of radioactive octreotide. The patient is then scanned with a gamma camera to detect the radiation emitted by the octreotide as it binds to somatostatin receptors in the body. The images produced by the scan can help doctors locate and assess the extent of neuroendocrine tumors.

Uses[edit]

Octreotide scans are primarily used to detect and locate neuroendocrine tumors, including carcinoid tumors, pancreatic islet cell tumors, and pheochromocytomas. They can also be used to monitor the effectiveness of treatment for these tumors.

Risks[edit]

As with any medical procedure, there are potential risks associated with an octreotide scan. These include allergic reactions to the octreotide, and exposure to radiation. However, the amount of radiation used in the scan is typically low and is considered safe for most patients.

See also[edit]

Octreotide_scan[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.